Frequency of Msx1/2 compound mutants
| Stage . | Total* . | Msx1-/- . | Msx2-/- . | Msx1-/-;Msx2+/- . | Msx1+/-;Msx2-/- . | Msx1-/-;Msx2-/- (%) . |
|---|---|---|---|---|---|---|
| E8.5 | 110 | 9 (8.2) | 7 (6.4) | 9 (8.2) | 11 (10.0) | 8 (7.3) |
| E9.5 | 815 | 48 (5.9) | 62 (7.6) | 103 (12.6) | 91 (11.2) | 47 (5.8) |
| E10.5 | 212 | 9 (4.2) | 6 (2.8) | 27 (12.7) | 24 (11.3) | 12 (5.7) |
| E12.5 | 237 | 10 (4.2) | 18 (7.6) | 26 (11.0) | 24 (10.1) | 13 (5.5) |
| E15.5 | 110 | 4 (3.6) | 10 (9.1) | 10 (9.1) | 19 (17.3) | 8 (7.3) |
| E16.5 | 81 | 6 (7.4) | 2 (2.5) | 18 (22.2) | 14 (17.3) | 5 (6.2) |
| E18.5 | 87 | 3 (3.4) | 9 (10.3) | 7 (8.0) | 9 (10.3) | 1 (1.1) |
| NB | 56 | 3 (5.4) | 8 (14.3) | 3 (5.4) | 11 (19.6) | 0 (0) |
| Stage . | Total* . | Msx1-/- . | Msx2-/- . | Msx1-/-;Msx2+/- . | Msx1+/-;Msx2-/- . | Msx1-/-;Msx2-/- (%) . |
|---|---|---|---|---|---|---|
| E8.5 | 110 | 9 (8.2) | 7 (6.4) | 9 (8.2) | 11 (10.0) | 8 (7.3) |
| E9.5 | 815 | 48 (5.9) | 62 (7.6) | 103 (12.6) | 91 (11.2) | 47 (5.8) |
| E10.5 | 212 | 9 (4.2) | 6 (2.8) | 27 (12.7) | 24 (11.3) | 12 (5.7) |
| E12.5 | 237 | 10 (4.2) | 18 (7.6) | 26 (11.0) | 24 (10.1) | 13 (5.5) |
| E15.5 | 110 | 4 (3.6) | 10 (9.1) | 10 (9.1) | 19 (17.3) | 8 (7.3) |
| E16.5 | 81 | 6 (7.4) | 2 (2.5) | 18 (22.2) | 14 (17.3) | 5 (6.2) |
| E18.5 | 87 | 3 (3.4) | 9 (10.3) | 7 (8.0) | 9 (10.3) | 1 (1.1) |
| NB | 56 | 3 (5.4) | 8 (14.3) | 3 (5.4) | 11 (19.6) | 0 (0) |
Total of all genotypes, including wild type, Msx1+/-, Msx2+/-, Msx1+/-;Msx2+/-, Msx1-/-, Msx2-/-, Msx1-/-;Msx2+/-, Msx1+/-;Msx2-/-, Msx1-/-;Msx2-/-. NB, newborn.